Ownership history in Gillson Capital LP Β· 9 quarters on record
This page tracks every 13F SEC filing in which Gillson Capital LP reported a position in PHYSICIANS RLTY TR (DOC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Gillson Capital LP underperformed the S&P 500 by β76.7% annually on this DOC position. Timing score: 62% (5/8 decisions correct). Average cost basis: $17.96. Maximum drawdown during holding period: β36.1%.
β Significantly underperformed the S&P 500 by 76.7% ann.
8 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
5 of 8 add/trim decisions correct
Best entry: $15.79 (2025 Q4) Β· Worst: $24.72 (2019 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
5 adds Β· 4 trims. Bought during 2 of 5 down-price quarters. π More buys than sells across the holding period.
π Gillson Capital LP has been actively increasing its DOC allocation β a bullish signal from insiders.
Currently 1.08% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size